Efficient heterodimerization of recombinant bi- and trispecific antibodies

Bioseparation

Volumn 9, Issue 3, 2000, Pages 179-183

  Schoonjans, R ^a   Willems, A ^a   Grooten, J ^a   Mertens, N ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Bispecific antibody; Cancer iummunotherapy; Heterodimerization; Immunoconjugate; Recombinant gene expression

Indexed keywords

ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; BISPECIFIC ANTIBODY; CARBOXY TERMINAL SEQUENCE; DIMERIZATION; HETERODIMERIZATION; MAMMAL CELL;

CHEMICAL BONDS; GENETIC ENGINEERING; IMMUNOLOGY; MOLECULAR STRUCTURE; ONCOLOGY;

CANCER IMMUNOTHERAPY; HETERODIMERIZATION;

ANTIBODIES;

ANTIBODIES, BISPECIFIC; ANTIBODY SPECIFICITY; DIMERIZATION; HUMAN; IMMUNOGLOBULIN FRAGMENTS; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOGLOBULINS, HEAVY-CHAIN; IMMUNOGLOBULINS, LIGHT-CHAIN; RECOMBINANT PROTEINS; TECHNOLOGY, PHARMACEUTICAL; TUMOR CELLS, CULTURED;

EID: 0033775743     PISSN: 0923179X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008120203269     Document Type: Article

References (20)

1. Treatment of mice bearing BCL1 lymphoma with bispecific antibodies
2. Production and characterization of bispecific single-chain antibody fragments
3. Production of functionally active murine and murine: Human chimeric F(ab')2 fragments in COS-1 cells
4. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system
5. Acquisition by the murine host of responsiveness toward various neoplastic cell lines, but not toward self, through adoptive transfer of a helper T-lymphocyte clone with antiself specificity
6. Assembly and secretion of heavy chains that do not associate posttranslationally with immunoglobulin heavy chain-binding protein
7. Radiolocalisation and imaging of stably HPLAP-transfected MO4 tumours with monoclonal antibodies and fragments
8. 'Diabodies': Small bivalent and bispecific antibody fragments
9. High volumetric yields of functional dimeric mini-antibodies in Escherichia coli, using an optimized expression vector and high- cell-density fermentation under non-limited growth conditions
10. Minibody: A novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts
11. An engineered bivalent single-chain antibody fragment that increases antigen binding activity
12. A small bispecific antibody construct expressed as a functional single-chain molecule with high tumor cell cytotoxicity
13. Construction, binding properties, metabolism, and tumor targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49
14. The first constant domain (C(H)1 and C(L)) of an antibody used as heterodimerization domain for bispecific miniantibodies
15. Efficient selection for high-expression transfectants with a novel eukaryotic vector
16. Optimization of experimental variables influencing reporter gene expression in hepatoma cells following calcium phosphate transfection
17. Miniantibodies: Use of amphipathic helices to produce functional, flexibly linked dimeric FV fragments with high avidity in Escherichia coli
18. 'Knobs-into-holes' engineering of antibody CH3 domains for heavy chain heterodimerization
19. Bispecific antibody-mediated lysis of placental and germ cell alkaline phosphatase targeted solid tumors in immunocompetent mice
20. High level secretion of a humanized bispecific diabody from Escherichia coli